European Commission awards BOOST Thyroid Phase 1 Research and Development grant for a Machine Learning solution to tackle autoimmune diseases

The Berlin-based healthtech startup BOOST Thyroid aims to improve the lives of over 300 million people impacted by Hashimoto’s disease and other thyroid conditions.

Berlin, Germany — 29 April, 2019 — Today BOOST Thyroid announced it was awarded a research and development grant by the European Commission’s Horizon 2020. The Phase 1 grant is awarded to companies that solve a true need in the health sector and connect basic science and patient empowerment, helping them to get their innovations faster to the market.

BOOST Thyroid, a free-to-use iOS app, delivers the best possible preventive health management solution to patients with autoimmune thyroid conditions. The company was founded in 2016 by Swedish-Croatian scientist, health advocate and Hashimoto’s patient Dr. Vedrana Högqvist Tabor and her partner, the Swedish-German scientist and engineer Dr. Mikael Högqvist Tabor. Their goal is to build a solution to help the hundreds of millions of people worldwide diagnosed with Hashimoto’s.

Since its founding, BOOST Thyroid has won the European Commission’s Horizon 2020 funding PERMIDES and INNOLABS, as well as a grant from the German Ministry for Education and Research. The company won the “Impact Maker in Sweden South” Venture Cup and has participated in the Fast Track Malmö Accelerator. Vedrana has been recognized as one of The Nordic 100, the most impactful and influential people in Nordic tech in 2018.

This grant will help to further develop business strategies and technology, and ultimately help the patient journey. This will be done by collaborating with research institutes Northeastern, the University of Oxford, and Charité in order to close the information gap and improve how patients and doctors communicate around the most common autoimmune condition, Hashimoto’s.

“The sustained user growth, medical interest and research opportunities we’ve gotten in the past year shows the market need for a digital thyroid solution,” said BOOST Thyroid co-founder and CEO Dr. Vedrana Hogqvist Tabor. “We are working on bringing the most scientific, accurate, and understandable information around all the aspects of the thyroid health to all of our users. In the past six months we have significantly evolved our product to the next level of technology, and contributed to increasing global awareness of thyroid conditions. With this most recent grant we will continue building our technology with a promise of helping hundreds of millions of people.”

Drs Högqvist Tabor combine science, technology, and the patient perspective. They seek to empower people around the globe in their daily life and in conversations with their doctors, so they can better understand their health patterns and adhere to a healthier lifestyle.